Cargando…
Telmisartan Mitigates TNF-α-Induced Type II Collagen Reduction by Upregulating SOX-9
[Image: see text] The proinflammatory cytokine tumor necrosis factor-α (TNF-α)-induced degradation of extracellular matrix (ECM), such as type II collagen in chondrocytes, plays an important role in the development of osteoarthritis (OA). Telmisartan, an angiotensin II (Ang-II) receptor blocker, is...
Autores principales: | Zhang, Xiuying, Dong, Yanfeng, Dong, Hanyu, Cui, Yanhui, Du, Qing, Wang, Xiaoli, Li, Lanlan, Zhang, Hongju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8154015/ https://www.ncbi.nlm.nih.gov/pubmed/34056329 http://dx.doi.org/10.1021/acsomega.1c01170 |
Ejemplares similares
-
Reduction of liver fibrosis by rationally designed macromolecular telmisartan prodrugs
por: Golder, Matthew R., et al.
Publicado: (2018) -
SOX9-activated FARSA-AS1 predetermines cell growth, stemness, and metastasis in colorectal cancer through upregulating FARSA and SOX9
por: Zhou, Taicheng, et al.
Publicado: (2020) -
Telmisartan and cardioprotection
por: Akhrass, Philippe R, et al.
Publicado: (2011) -
Telmisartan alleviates collagen type III glomerulopathy: A case report with literature review
por: Guo, Qiaoyan, et al.
Publicado: (2020) -
Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis
por: Zhu, Haibo, et al.
Publicado: (2013)